EUVIMEDEUVIMED entdecken
Open Access

LAPTM4B Confers Resistance to EGFR-TKIs by Suppressing the Proteasomal Degradation of ATP1A1 in Non-small Cell Lung Cancer

Dan Liu, Minxia Liu, Dongjin Lv, Yuxiang Li, Hongjuan Guo, Bingxiao Lu, Hao Leng, Ruyu Yan, Hongtao Yu, Tomas Blom, Kecheng Zhou

International Journal of Biological Sciences · 01.01.2026 · 22 (1) · 1-24

DOI: 10.7150/ijbs.115365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 01.01.2026. Verfasst von Dan Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Anhui Medical University, Hefei, 230032, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proteasome Endopeptidase Complex, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsProteasome Endopeptidase ComplexMembrane ProteinsProtein Kinase InhibitorsHumansErbB ReceptorsDrug Resistance, NeoplasmAnimalsCell Line, TumorMiceMice, NudeGefitinibOncogene Proteins

Stichwörter der Autor:innen

ATP1A1EGFR-TKIs resistanceLAPTM4BNon-small cell lung cancerProteasomal degradation.

Substanzen

ErbB ReceptorsProteasome Endopeptidase ComplexLAPTM4B protein, humanMembrane ProteinsProtein Kinase InhibitorsGefitinibEGFR protein, humanOncogene Proteins

Autor:innen und Institutionen

  • School of Life Sciences, Anhui Medical University, Hefei, 230032, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
  • Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki, 00290, Finland.
  • Department of Clinical Research, The Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), Kunming, China.
  • Department of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki, 00014, Finland.
  • Minerva Foundation Institute for Medical Research, Helsinki, 00014, Finland.

Zitieren

APA

Liu, D., Liu, M., Lv, D., Li, Y., Guo, H., Lu, B., Leng, H., Yan, R., Yu, H., Blom, T., & Zhou, K. (2026). LAPTM4B Confers Resistance to EGFR-TKIs by Suppressing the Proteasomal Degradation of ATP1A1 in Non-small Cell Lung Cancer. International Journal of Biological Sciences, 22(1), 1-24. https://doi.org/10.7150/ijbs.115365

Vancouver

Liu D, Liu M, Lv D, Li Y, Guo H, Lu B, et al. LAPTM4B Confers Resistance to EGFR-TKIs by Suppressing the Proteasomal Degradation of ATP1A1 in Non-small Cell Lung Cancer. International Journal of Biological Sciences. 2026;22(1):1-24. doi:10.7150/ijbs.115365

BibTeX
@article{Liu2026,
  author = {Liu, Dan and Liu, Minxia and Lv, Dongjin and Li, Yuxiang and Guo, Hongjuan and Lu, Bingxiao and Leng, Hao and Yan, Ruyu and Yu, Hongtao and Blom, Tomas and Zhou, Kecheng},
  title = {LAPTM4B Confers Resistance to EGFR-TKIs by Suppressing the Proteasomal Degradation of ATP1A1 in Non-small Cell Lung Cancer},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {1},
  pages = {1--24},
  doi = {10.7150/ijbs.115365}
}
Kostenlos starten →